<DOC>
	<DOC>NCT00326131</DOC>
	<brief_summary>The first purpose of this study is to determine how the body absorbs, metabolizes, and eliminates a single dose of BMS-275183 (labeled with radioactive carbon). Secondly, to measure the levels of BMS-275183 in your blood, study the safety of the drug, and to see what effects it has on your cancer.</brief_summary>
	<brief_title>A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced Cancer</brief_title>
	<detailed_description />
	<criteria>Nonhematological malignancy that has progressed on standard therapy No more that 3 prior chemotherapies given for advanced cancer Adequate renal, hepatic and hematologic function Uncontrolled or significant pulmonary or cardiovascular disease Active Brain metastases Inability to swallow capsules Serious uncontrolled medical disorder or active infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>